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1  | INTRODUCTION
Bipolar disorder (BP) is a mental illness characterized by pathological 
mood swings, ranging from mania to depression. The course of BP is 
unpredictable, often severe, and typically causes major disruption in 
circadian rhythms and cognitive function1,2 which results in chronic 
impairment in personal, social, and vocational domains. To reduce 
these risks, the World Health Organization recommends that indi-
viduals with BP monitor their mood, such as keeping a daily log to re-
cord mood symptoms.3 Monitoring symptoms is also a prerequisite 
for measuring mood instability in BP and for delivering interventions 
that address needs of specific individuals in the moment.4-6 Many 
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Abstract
Objectives: Self-monitoring is recommended for individuals with bipolar disorder, 
with numerous technological solutions available. This study aimed to identify basic 
components of these solutions that increase engagement with self-monitoring.
Methods: Participants with bipolar disorder (n = 47) monitored their symptoms with 
a Fitbit and a smartphone app and were randomly assigned to either review or not 
review recorded symptoms weekly. We tested whether individuals would better ad-
here to and prefer monitoring with passive monitoring with an activity tracker com-
pared to active monitoring with a smartphone app and whether individuals would 
better adhere to self-monitoring if their recorded symptoms were reviewed with an 
interviewer.
Results: Monitoring with a smartphone app achieved similar adherence and prefer-
ence to Fitbit (P > .85). Linear mixed effects modeling found adherence decreased 
significantly more over the study for the Fitbit (12% more, P < .001) even though 
more participants reported they would use the Fitbit over a year compared to the app 
(72.3% vs 46.8%). Reviewing symptoms weekly did not improve adherence, but most 
participants reported they would prefer to review symptoms with a clinician (74.5%) 
and on monthly basis (57.5%) compared to alternatives. Participants endorsed sleep 
as the most important symptom to monitor, forgetfulness as the largest barrier to 
self-monitoring, and raising self-awareness as the best reason for self-monitoring.
Conclusions: We recommend a combined strategy of wearable and mobile monitor-
ing that includes reminders, targets raising self-awareness, and tracks sleep. A clini-
cian may want to review symptoms on a monthly basis.
Trial registration: Clini calTr ials.gov NCT03358238.
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mobile and wearable technologies are available for individuals to 
self-monitor their symptoms,7-12 but engagement is a common prob-
lem.13-15 This study evaluated engagement strategies for individuals 
with BP to monitor symptoms longitudinally.
Smartphone apps are the most common technology for inter-
active self-monitoring symptoms of psychiatric illness. They allow 
the user to record symptoms at set intervals over time. Individuals 
with mental illness are generally open to the use of mobile tech-
nology, and point to self-awareness and communication between 
patients and clinicians as reasons for engaging in self-monitor-
ing.7,16-18 Visualization of symptom patterns over time may also 
be considered a specific strategy for increasing engagement.17 
Primarily focused on qualitative information, few studies have 
provided quantitative evidence for engagement strategies in self-
monitoring of BP.
One concern is that individuals may engage in self-monitor-
ing less with smartphone apps when compared to monitoring ap-
proaches based on sensors and wearable devices. Smartphone apps 
require that users actively record their symptoms, a burden that may 
decrease engagement with users preferring more automated ways 
to record symptoms.7 They also involve subjective measurements, 
which may lead to less accurate or less biologically relevant markers 
of symptoms.6,14,16 Sensors and wearable devices allow symptoms 
to monitored passively and objectively. For example, MONARCA,19 
PRIORI,20 and Bi-Affect21 use patterns of speech and behavior from 
recorded calls, keystrokes, number of phone calls, and duration of 
phone calls to predict mood. Wearable devices, such as activity 
trackers, also offer direct and indirect measurements of a wide range 
of clinically important variables of BP such as mood, physical activ-
ity, heart rate variability, sleep patterns, and circadian rhythms.6,22,23 
Yet, it remains unknown whether these passive approaches improve 
engagement in monitoring compared to active monitoring through 
smartphone apps.
This study collected quantitative data on engagement in self-
monitoring over 6 weeks from individuals with BP (n = 47). Passive 
monitoring was compared to active monitoring with participants 
using a smartphone app to log symptoms and an activity tracker 
to track sleep, activity, and heart rate. Participants were randomly 
assigned to either a review or not review self-reported symptoms. 
Objective measures of engagement were obtained throughout the 
study, with subjective measurements obtained at study end. We hy-
pothesized that participants will exhibit better adherence rates and 
prefer passive monitoring of symptoms than active monitoring. We 
also hypothesized higher adherence rates for individuals who review 
recorded symptoms.
2  | MATERIALS AND METHODS
The protocol for this study was previously published,24 which con-
tains additional study details. This paper presents the first analysis 
of data collected under the protocol and focuses on primary out-
comes as listed in the protocol. The data that support the findings 
of this study are openly available in Mendeley Data at http://doi.
org/10.17632/ fsy7m 755g6.1 under “Engagement in Mobile and 
Wearable Health Monitoring for Bipolar Disorder.”
2.1 | Participants
A total of 50 individuals with BP were recruited from the Prechter 
Longitudinal Study of Bipolar Disorder25 to participate in a 6-week 
two-arm randomized control trial. In the Prechter Longitudinal Study 
of Bipolar Disorder, participants are diagnosed using the Diagnostic 
Interview for Genetic Studies (DIGS)26 with diagnoses reviewed 
by two clinicians after initial evaluation and reevaluated when sus-
pected to change based on a clinically relevant event. Each partici-
pant used their own smartphone for the study, and no participants 
were excluded from the study because they did not have a compat-
ible smartphone. This 6-week study was approved by Institutional 
Review Boards at the University of Michigan (HUM126732) and 
University of Wisconsin (2017-1322). Written consent was obtained 
on all individuals.
2.2 | Study design
Participation involved 7 weekly phone interviews and the use of mo-
bile and wearable technology over 6 weeks. Each participant was pro-
vided a Fitbit Alta HR to collect information about physical activity, 
sleep, and heart rate. They also downloaded a smartphone applica-
tion which prompted the user to log six symptoms each morning and 
evening: three for mania (increased energy, rapid speech, irritability) 
and three for depression (depressed mood, fidgeting, fatigue). In addi-
tion to logging symptoms, the app also allowed participants to review 
and visualize information collected from their answers and from the 
Fitbit. This information was presented to participants in five graphs: 
(i) a line graph for tracking depressive symptoms over time, (ii) a line 
graph tracking manic symptoms over time, (iii) a combined line graph 
and bar graph for tracking sleep over time, (iv) a combined line and 
bar graph for tracking resting heartrate and total daily step count over 
time, and (v) a combined line and bar graph for tracking sleep periods 
and estimated circadian phase.” See the protocol paper for details on 
app development.25 At study start and end, participants were assessed 
over the phone with a Young Mania Rating Scale (YMRS)27 depressive 
symptoms were assessed with a Structured Interview Guide for the 
Hamilton Rating Scale of Depression (SIGHD)28; and general health is 
assessed using the 36-Item Short Form Health Survey (SF-36) devel-
oped by RAND.29 At study end, the interviewer also conducted a 17-
item survey to assess engagement.24 All participants were interviewed 
by a trained research technician. In between the start and end of the 
study, participants were assessed weekly for manic and depressive 
symptoms using the YMRS and SIGHD. In addition to these assess-
ments, each participant had a 50-50 chance of being randomly as-
signed to either reviewing data recorded by the Fitbit and app after the 
weekly assessments (Arm R = Review) or not reviewing this data (Arm 
NR = No Review). Participants were randomized using block randomi-
zation and stratifying by age ( <40 years of age vs ≥40 years of age) and 
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sex. Randomization is detailed in the previously published protocol for 
this study.24
2.3 | Measures of engagement
Primary measures were identified prior to study start: participant pref-
erence at end of study based on whether they state they are more 
likely to use an activity tracker over an app to monitor their symptoms 
and overall adherence to monitoring with an activity tracker and app. 
Overall adherence for the app was measured as the proportion of study 
days with at least 50% of daily self-reports questions completed. The 
criterion of 50% was chosen to align with future research and clinical 
goals that would require at least once-a-day recording of symptoms. 
Overall adherence for the activity tracker was measured as percent 
study days with at least 12 hours of activity tracking, determined in-
directly using total minutes Fitbit measures heartrate. These primary 
measures of adherence and engagement were accompanied by other 
responses on the engagement survey to further examine reasons why 
an individual might monitor their symptoms with either a smartphone 
or an activity tracker. Daily adherence was also measured based on the 
proportion of minutes (out of max 1440 minutes) for which the Fitbit 
was worn, as determined from heartrate information, and proportion 
of symptoms (out of max 12) logged on the app.
2.4 | Statistical tests
Four hypothesis tests were identified prior to study start to be tested. 
Binomial tests were used to test hypotheses that (i) participants have 
equal preference for the app as the Fitbit and (ii) participants have 
equal overall adherence to the app as the Fitbit. Two-sample t tests 
were used to test hypotheses that mean adherence rate were equal 
between study arms for the (iii) Fitbit and (iv) app. In addition, 95% 
Clopper-Pearson confidence intervals were estimated for estimated 
proportions using a binomial distribution and 95% confidence inter-
vals were estimated for means using a normal distribution. Linear 
mixed effects model was constructed for daily adherence. The model 
included five fixed effects: time (ie, study day), method (Fitbit vs. app), 
study arm (Arm R vs. Arm NR), age, and sex. The model included a 
random intercept and random slope for time to account for repeated 
measurements on each participant. Based on the constructed model, 
differences in mean daily adherence was estimated as a function of 
fixed effects with F-tests used to measure significance. Significance 
was considered a P-value less than .05.
3  | RESULTS
3.1 | Sample characteristics
The study recruited 50 participants with a diagnosis of BP. Three 
participants were excluded for not completing the study beyond the 
first week. One participant died between the consent date and the 
start of the study, another participant was lost to follow-up between 
the consent date and study start, and a third participant discontin-
ued participation after the first weekly interview due to discomfort 
with wearing the Fitbit. The included population were an average 
( ± SD) of 41.9 ± 10.8 years of age and 53.1% female. The major-
ity were white (85.1%), not Hispanic (87.2%), and were diagnosed as 
Bipolar I (80.0%). Study arms did not differ significantly by race, age, 
sex, ethnicity, or diagnosis (P > .2). Sample characteristics are sum-
marized in Table 1.
3.2 | Activity tracker vs smartphone app
Because activity trackers may require less effort than smartphone 
apps, our initial hypothesis was that participants would better 








Age, years (mean ± SD) 41.3 ± 10.7 42.4 ± 11.2 0.12 1 .73
Female (n [%]) 13 (54.2) 12 (52.2) 0.02 1 .89
Race (n [%])   2.41 4 .66
White 21 (87.5) 19 (82.6)    
Black or African 
American
2 (8.3) 1 (4.3)    
Asian 1 (4.2) 1 (4.3)    
American Indian or 
Alaskan Native
0 (0) 1 (4.3)    
More than one 0 (0) 1 (4.3)    
Hispanic (n [%]) 22 (91.7) 19 (82.6) 0.87 1 .35
Diagnosis (n [%])   3.11 2 .21
Bipolar I 15 (62.5) 17 (73.9)    
Bipolar II 6 (25) 6 (26.1)    
Bipolar NOS 3 (12.5) 0 (0)    
TA B L E  1   Characteristics of population 
included in analysis by study arm. 
participants were randomized to either 
review (Arm R) or not review (Arm NR) 
recorded over the study. Arms were 
balanced for age and sex
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tracker as opposed to active monitoring with a smartphone app. 
However, we found the opposite. Participants spent slightly more 
days engaging with the app than with the Fitbit in terms of over-
all adherence: recording at least half of their symptoms with the 
app for an average (95% CI) of 81.8% (73.1%-90.4%) days in the 
study compared to wearing their Fitbit at least half of a day for 
an average of 77.8% (68.1%-87.6%) days in the study (Figure 1A). 
Based on a binomial test, these differences were not significant 
(P = .75). However, linear mixed effects modeling (see Table A1 
in Appendix) found a significant interaction between time and 
self-monitoring method whereby participants were significantly 
more likely, by 7.2%, at study start to adhere to monitoring with 
the Fitbit than with the smartphone app at study start (P < .001, 
F[1,3916] = 14.1), but 4.9% less likely at study end (P = .008, 
F[1,3916] = 7.0). Figure 1B illustrates differences in adherence by 
study day, defined as the percent symptoms logged on the day and 
for the Fitbit was measured for the Fitbit as the percent time Fitbit 
is worn in a day. Differences from study start to end are explained 
by a significant decline of 18.1% in Fitbit adherence over the study 
(P < .001, F[1,3916] = 23.8) compared to only 6.1% decline in app 
adherence over the study (P = .10, F[1,3916] = 2.7). Adherence 
was not significantly influenced by age or sex at either study start 
or study end (P > .3), but there was a significant interaction be-
tween method, time, and age whereby Fitbit adherence decreased 
a significant 23.4% for participants at 50 years of age (P < .001, 
F[1,3916] = 24.1) compared to 10.2% for participants at 30 years 
of age (P = .06, F[1,3916] = 3.4). Further, app adherence decreased 
a nonsignificant 5.5% for participants at 50 years of age (P = .25, 
F[1,3916] = 1.3) and a similar 7.0% for participants at 30 years of 
age (P = .21, F[1,3916] = 1.6). In sum, these objective measures sug-
gest that except at study start, participants better adhere to active 
monitoring with a smartphone app over 6 weeks compared to pas-
sive monitoring with an activity tracker.
We also hypothesized participants would prefer passive monitoring 
with an activity tracker as opposed to active monitoring with a smart-
phone app (Figure 1C). Indeed, based on participant responses at study 
end, most participants stated that the Fitbit required significantly less 
effort than the app (78.7% [64.3%-89.3%]; P = 1e-4) and was slightly 
less complicated to use (59.6% [44.3%-73.6%]; P = .24). Yet, they were 
only slightly more likely to state that they would use the Fitbit over 
than the app (59.6% [44.3%-73.6%]; P = .24). At the same time, par-
ticipants were slightly more likely to state that they learned less from 
the Fitbit over the app (44.7% [30.2%-59.9%], P = .56) and that the 
Fitbit did less to improve their emotional health (38.3% [24.5%-53.6%], 
P = .14). Thus except for perception of effort required by either self-
monitoring method, there were few meaningful differences in partici-
pant preference for an activity tracker over a smartphone app.
In addition to head-to-head comparisons, we examined general at-
titudes toward using the Fitbit and the app (Figure 1D). Interestingly, 
72.3% of participants stated they were willing to use the Fitbit over a 
F I G U R E  1   Comparison between active monitoring with a smartphone app and passive monitoring with a Fitbit. A, Mean (± SE) 
overall adherence rates across participants was measured for the app and the Fitbit. B, Mean (± SE) adherence by study day across 
participants was measured for the app and the Fitbit. C, End of the study preference across participants with 95% confidence intervals was 
measured between using an app over the Fitbit. D, Participants reported they would use the Fitbit over a year but not the app, and most 
participants found that the Fitbit and the app were not at all complicated and required little to no effort [Colour figure can be viewed at 
wileyonlinelibrary.com]
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year compared to 46.8% for the app, even though adherence rates of 
the Fitbit declined significantly compared to the app. Moreover, while 
the Fitbit was perceived to require less effort and was less compli-
cated than the app, most participants (>85%) thought each approach 
required little to no effort and slightly or not complicated.
3.3 | Reviewing vs not reviewing 
monitored symptoms
We also hypothesized that reviewing symptoms that a participant 
recorded over the past week would increase adherence. Based on a 
two-sample t test or linear effects modeling (Table A1), we did not 
find a main effect of between individuals who were randomly assigned 
to review their recorded symptoms with an interviewer (Arm R) com-
pared to individuals who did not review their recorded symptoms (Arm 
NR) (P > .8, Figure 2A). However, there were significant interactions 
in the linear mixed effects model that involved arm (R vs NR), method 
(Fitbit vs app), age, and sex (male vs. female). As a result, reviewing 
symptoms (arm R) had a significant positive effect only on app adher-
ence and only for younger women (an estimated 43.0% increase in app 
adherence for women at 30 years; P = .001, F[1,3916] = 10.5). By com-
parison, reviewing symptoms increased Fitbit adherence by a nonsig-
nificant 10.1% for women at 30 years of age (P = .45, F[1,3916] = 0.6). 
Moreover, reviewing symptoms had a slight negative effect in men 
at 30 years of age: decreased app adherence by an estimated 26.0% 
(P = .10, F[1,3916] = 2.8) and Fitbit adherence by 24.8% (P = .11, 
F[1,3916] = 2.5); and in women at 50 years of age: decreased app ad-
herence by 25.7% (P = .05, F[1,3916] = 3.7) and Fitbit adherence by 
6.8% (P = .61, F[1,3916] = 0.3). There was a negligible effect on either 
app or Fitbit adherence for men at 50 years of age (P > .75). Thus ex-
cept for younger women, reviewing symptoms does not increase ad-
herence and may even decrease adherence for other individuals.
Even though reviewing symptoms did not have strong effect on 
adherence, the majority of participants (57%) reported that they 
would like to review their recorded symptoms on a monthly basis 
as opposed to weekly, yearly, or never (Figure 2B). Additionally, the 
majority of participant (74%) reported that they would like to review 
their recorded symptoms with a clinician as opposed to a family 
member, friend, someone with BP, or someone they did not know. 
These data would suggest that there is a role for a clinician reviewing 
recorded symptoms with a patient on a monthly basis.
3.4 | Symptom visualization
The app had provided participants with charts and graphs to visu-
alize symptoms, which we thought would improve engagement in 
self-monitoring. (Figure 3). Most participants stated they would con-
tinue to visualize their symptoms for over a year (70.2%) and thought 
visualization of symptoms was slightly or not complicated (93.6%). 
Moreover, most participants (63.8%) thought they learned a fair 
amount or a lot from visualizing their symptoms.
3.5 | Top symptoms, barriers, and uses of self‐
monitoring
We also asked each participant at study end their top three symp-
toms, top three barriers, and top three reasons for self-monitoring 
(Figure 4). The top barrier preventing participants from using tech-
nology to monitor their symptoms was forgetfulness, with 55.3% 
of participants placing this barrier in their top 3. Participants were 
also asked to identify the symptom or pattern that they would 
most like to be able to monitor, and 70.2% of participants consid-
ered sleep to be one of their top 3 symptom or pattern to moni-
tor. Furthermore, participants were asked what they felt the top 
F I G U R E  2   Comparison between reviewing recorded symptoms weekly (Arm R) and not reviewing recorded symptoms weekly (Arm 
NR). A, Mean (± SE) overall adherence rates across participants were measured by study arm. B, Most individuals stated they would want to 
review their symptoms on a monthly basis and preferably with a clinician [Colour figure can be viewed at wileyonlinelibrary.com]
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use of technology for monitoring their symptoms would be, and 
the majority responded with to raise self-awareness as a top 3 
use (78.7%). The least-endorsed use was to alert someone when 
they are in trouble. Indeed, most participants felt overall that self-
monitoring of symptoms helped them learn a fair amount or a lot 
about their illness (70.2%) but did not improve or improved very 
little their emotional health (85.1%). Thus, raising self-awareness 
appears to be an important target for engaging individuals with BP 
in self-monitoring.
4  | DISCUSSION
This study tested engagement of individuals with BP in the use of 
technology for monitoring daily symptoms. Participants tracked 
symptoms actively by completing self-report assessments on a 
smartphone app and passively with a Fitbit activity tracker. About 
50% participants were randomly assigned to review their re-
corded symptoms weekly with an interviewer. Engagement strat-
egies of interest were passive monitoring vs active monitoring, 
communication of recorded symptoms with an interviewer, visu-
alization, raising self-awareness, among others. In contrast to 
what we hypothesized, we found mixed reactions and adherence 
rates between reviewing and not reviewing recorded symptoms 
and between active and passive monitoring. Reviewing recorded 
symptoms did not significantly improve adherence rates, but 
participants still predominately endorsed the idea of reviewing 
symptoms with a clinician on a monthly basis over alternatives (eg, 
friend or family member; yearly, weekly, or never). Adherence was 
slightly higher for the self-report app, particularly at the end of 
the study, and participants reported they learned more from the 
study app and that it did more to improve their emotional health. 
Yet, participants reported that the Fitbit was easier to use and that 
they were more likely to use the Fitbit.
An explanation for this passive vs. active conflict lies within 
the participant's responses to other questions at study end. 
Participants reported the main barrier that would prevent them 
from using technology to monitor their symptoms was forgetful-
ness. We speculate that individuals were more likely to remem-
ber to keep their smartphone close than remember to wear the 
F I G U R E  3   Most participants stated they would continue to visualize their symptoms for over a year and thought visualization of 
symptoms was not complicated but required a fair amount or a lot of effort
F I G U R E  4   Other insights into participant engagement. Top three A, barriers, B, symptoms, and C, uses for monitoring were collected. 
Forgetfulness was most commonly endorsed barrier, raising self-awareness was most commonly endorsed use, and sleep was the mostly 
commonly endorsed symptom. D, General attitudes were also collected, with most participants stating that they learn a fair amount or a lot 
from monitoring but did not feel their emotional health improved [Colour figure can be viewed at wileyonlinelibrary.com]
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Fitbit. Many individuals already keep their smartphone with them, 
but we expect fewer individuals have a similar habit of wearing a 
Fitbit. Furthermore, provided their smartphone is close, then par-
ticipants were then reminded via push notifications to respond to 
self-report symptoms through the app. In contrast, participants 
were not reminded to wear the Fitbit. They might have taken the 
Fitbit off to shower or charge the device and forget to put the 
Fitbit back on. Some may have even taken the Fitbit off at night 
because it is too uncomfortable to wear during sleep. Although 
participants found the Fitbit required less effort, the question-
naires were intentionally brief (six questions). The smartphone app 
also contained graphs of participant symptoms, thus checking this 
progress may further remind participants to complete the self-re-
port questionnaires.
Meanwhile, the data show participants felt the top reason for using 
technology to monitor symptoms was to raise self-awareness, which 
is consistent with other studies.7,16-18 The study app forces partici-
pants to reflect on their symptoms. This active monitoring could raise 
self-awareness, which is important to participants. The app, however, 
did not ask about sleep, the most popular symptom or pattern partici-
pants wanted to monitor. Sleep was monitored by the Fitbit, but many 
participants reported to study staff that the sleep patterns they saw 
using the Fitbit contrasted their own recollection of their sleep. Often 
realizing their sleep was more restless than they recalled.
Clinicians may thus utilize both an active device, such as a smart 
phone app, and a passive device, such as a Fitbit, to track their 
patients’ daily symptoms and to review recorded symptoms on a 
monthly basis. A combined approach provides flexibility depending 
on the patient's preferences while increasing patient's own self-
awareness and allowing for some data collection to require minimal 
effort. A self-report app should also ask questions about sleep, and 
automated reminders should accompany any form of passive moni-
toring, since forgetfulness is the greater barrier.
Another meaningful finding was that most participants reported 
they learned something about their illness but did not feel their 
mood improved. There are several possible reasons for this finding. 
Participants were often euthymic, leaving little room for their mood 
to improve. Participants who were depressed were sometimes dis-
heartened from monitoring. Monitoring might also exacerbate po-
tential feelings of paranoia in hypomanic or manic mood episodes, as 
previous studies have found.17,18 Another reason may be the short 
duration of the study. Although monitoring could lead to earlier in-
terventions and a better relationship between the patient and the 
clinician,16-18 this study may not have been long enough for improve-
ment to be observed.
However, mobile and wearable monitoring will not benefit all 
patients the same way. Variation in patient needs calls for flexible 
systems.17 For example, reviewing symptoms was found to have a 
positive effect on engagement only for younger women and only for 
the app, and Fitbit adherence declined significantly more for indi-
viduals at 50 years of age compared to individuals at 30 years of age 
and compared to the app. Future studies may thus want to focus 
on reviewing symptoms with young women or provide reminders to 
older individuals to wear an activity tracker. Moreover, some partic-
ipants shared qualitative feedback in this study that they wanted to 
provide context to mood ratings which would help them reflect on 
what was going on in their lives. Similar feedback had been given in 
a prior study.18 In short, clinicians may want to review with patient 
after a trial period how they feel about monitoring.
This study has several limitations. The study required partici-
pants to utilize mobile and wearable health technology; thus, there 
was likely a selection bias based on participants’ willingness or in-
terest in using smartphone and wearable technology. Another lim-
itation is that an activity tracker was used for passive monitoring, 
but there are other forms of passive monitoring such as keystrokes, 
GPS, acoustics, call patterns,19-21 which may achieve better ad-
herence rates than an activity tracker because they are collected 
directly from a smartphone. Another limitation is all participants 
were assessed weekly, which may dampen the effect of review-
ing recorded symptoms on engagement compared to a situation 
in which only those who reviewed recorded symptoms interacted 
with an interviewer. In addition, this study had a small number of 
subjects in each study arm (Review Arm = 24, No-Review Arm = 23) 
and the sample was majority white and not Hispanic, limiting study 
findings to other populations. The duration of the study was also 
short, only 6 weeks long which may not have been enough time 
to fully examine adherence rates to the technologies in this study 
over time. Some subjects encountered difficulties in initial set up 
of Fitbit and study app. Problems that encountered were primarily 
user error, such as not making sure Bluetooth was turned on to 
sync Fitbit data, forgetting to download the Fitbit app separately, 
or not adjusting wake and sleep times in the study app when rou-
tines changed, which affected the notifications to complete the 
self-report questionnaires. Although each of these problems were 
addressed by the research technician, these could present poten-
tial problems outside of a research study if an individual does not 
have someone checking in on their progress with the technologies. 
We also did not keep track of whether a participant used an iOS or 
Android device, which may be an important factor in determining 
participant engagement. Lastly, our study was also not sufficiently 
powered to look at individual differences in responses to our en-
gagement at study end, leaving questions about whether there are 
sex or age differences in user preferences related to engagement.
In conclusion, this study investigated how best to engage indi-
viduals with BP in mobile and wearable health monitoring. Overall, 
adherence rates were high, and the reaction to the mobile health 
technology was predominantly positive. Insights gained should im-
prove patient experience not only with self-monitoring, but also help 
develop standardized practices for mobile health research in psychi-
atry.30 Insights can also be integrated into treatment solutions that 
use digital health technology such as creating goals,31 increasing ac-
cess32; and delivering psychosocial interventions.33,34 Furthermore, 
it may not be beneficial to all patients to use technology 24/7, thus 
it is important to remain flexible and listen to patients’ preferences 
because if they do not feel they benefit from the technology, they 
will have low motivation to use it.
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APPENDIX 
TA B L E  A 1   Results from linear mixed effects modeling of adherence rates as a function of methodology (app vs fitbit), sex, age, study 
arm (review vs no review), and time. Age was centered around 40 years and has unit decades. Time was scaled to be 0 at study start and 1 at 
study end. Binary variables were first encoded as Fitbit = 1 and App = 0 for Method, as Female = 1 and Male = 0 for Sex, and Review = 1 and 
No review = 0 for Arm; and then were centered around their mean
 95% CI
Name Estimate SE t df P Lower Upper
(Intercept) 72.1 3.4 21.3 3916 1.4E-95 65.5 78.8
Time -12.1 3.3 -3.6 3916 3.0E-04 -18.6 -5.5
Method 1.1 0.9 1.2 3916 .22 -0.7 3.0
Age -2.1 3.2 -0.7 3916 .51 -8.5 4.2
Sex -1.3 6.8 -0.2 3916 .85 -14.6 12.0
Arm -4.3 6.8 -0.6 3916 .53 -17.6 9.0
Time:Method -12.0 3.2 -3.7 3916 2.1E-04 -18.4 -5.7
Time:Age -2.9 3.2 -0.9 3916 .36 -9.2 3.3
Method:Age -0.3 0.9 -0.3 3916 .77 -2.0 1.5
Time:Sex -7.8 6.7 -1.2 3916 .24 -20.9 5.3
Method:Sex 3.9 1.9 2.1 3916 .04 0.2 7.5
Age:Sex -4.5 6.4 -0.7 3916 .48 -17.0 8.1
Time:Arm -6.4 6.7 -1.0 3916 .34 -19.5 6.7
Method:Arm 0.8 1.9 0.4 3916 .66 -2.9 4.5
Age:Arm -5.5 6.5 -0.8 3916 .40 -18.2 7.2
Sex:Arm 11.4 13.6 0.8 3916 .40 -15.2 38.0
Time:Method:Age -7.3 3.1 -2.4 3916 .02 -13.4 -1.3
Time:Method:Sex -3.3 6.5 -0.5 3916 .61 -16.0 9.4
Time:Age:Sex -10.9 6.3 -1.7 3916 .08 -23.3 1.5
Method:Age:Sex -1.8 1.8 -1.0 3916 .32 -5.2 1.7
Time:Method:Arm -17.9 6.5 -2.8 3916 .01 -30.6 -5.2
Time:Age:Arm -1.1 6.4 -0.2 3916 .86 -13.6 11.4
Method:Age:Arm 14.9 1.8 8.3 3916 1.0E-16 11.4 18.4
Time:Sex:Arm -10.3 13.4 -0.8 3916 .44 -36.6 15.9
Method:Sex:Arm -6.2 3.7 -1.7 3916 .10 -13.6 1.1
Age:Sex:Arm -34.1 12.8 -2.7 3916 .01 -59.2 -9.0
Time:Method:Age:Sex -6.5 6.1 -1.1 3916 .29 -18.5 5.5
Time:Method:Age:Arm -5.0 6.2 -0.8 3916 .42 -17.1 7.1
Time:Method:Sex:Arm 5.0 13.0 0.4 3916 .70 -20.4 30.5
Time:Age:Sex:Arm -24.3 12.6 -1.9 3916 .05 -49.1 0.5
Method:Age:Sex:Arm 23.5 3.5 6.6 3916 3.3E-11 16.6 30.5
Time:Method:Age:Sex:Arm -3.5 12.2 -0.3 3916 .77 -27.6 20.5
